Ambev (NYSE:ABEV) Raised to Buy at Wall Street Zen

Ambev (NYSE:ABEV) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

Several other brokerages have also recently issued reports on ABEV. Scotiabank cut Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. UBS Group upped their target price on shares of Ambev from $2.65 to $2.90 and gave the stock a “sell” rating in a research note on Thursday, May 14th. Barclays raised their target price on shares of Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings cut shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, May 6th. Five equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Ambev presently has an average rating of “Reduce” and a consensus price target of $3.09.

Ambev Trading Down 0.5%

NYSE:ABEV opened at $3.10 on Friday. The firm has a market cap of $48.78 billion, a PE ratio of 15.47, a price-to-earnings-growth ratio of 1.82 and a beta of 0.65. The stock has a fifty day moving average price of $3.13 and a 200 day moving average price of $3.03. Ambev has a 12-month low of $2.10 and a 12-month high of $3.45. The company has a current ratio of 1.02, a quick ratio of 0.76 and a debt-to-equity ratio of 0.02.

Ambev (NYSE:ABEV) last released its earnings results on Thursday, July 30th. The company reported $0.04 EPS for the quarter, hitting the consensus estimate of $0.04. Ambev had a return on equity of 17.48% and a net margin of 18.47%.The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $4.05 billion. Sell-side analysts anticipate that Ambev will post 0.2 earnings per share for the current fiscal year.

Insider Transactions at Ambev

In other news, insider Paulo Andre Zagman sold 136,250 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $3.41, for a total transaction of $464,612.50. Following the sale, the insider owned 230,535 shares of the company’s stock, valued at approximately $786,124.35. This trade represents a 37.15% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ricardo Manuel Frangat Moreira sold 468,040 shares of the business’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $3.08, for a total value of $1,441,563.20. Following the sale, the director owned 3,000,000 shares of the company’s stock, valued at approximately $9,240,000. The trade was a 13.50% decrease in their position. The SEC filing for this sale provides additional information.

Institutional Trading of Ambev

Several institutional investors have recently modified their holdings of the stock. Monument Capital Management acquired a new position in shares of Ambev in the 4th quarter valued at $25,000. First Trust Advisors LP acquired a new stake in Ambev during the 3rd quarter worth $25,000. Integrated Wealth Concepts LLC acquired a new stake in Ambev during the 1st quarter worth $26,000. IHT Wealth Management LLC purchased a new stake in Ambev in the fourth quarter valued at $27,000. Finally, S Harris Financial Group LLC purchased a new stake in Ambev in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 8.13% of the company’s stock.

Ambev News Roundup

Here are the key news stories impacting Ambev this week:

• Positive Sentiment: Ambev’s board approved approximately R$2.7 billion in interest-on-capital payments for 2026, including the third and final installment. The payout supports the stock’s income appeal and signals continued cash-return capacity. Ambev Approves R$2.7 Billion in Interest on Capital Payments for 2026
• Positive Sentiment: The brewer is preparing for hotter conditions associated with El Niño. Warmer weather could support demand for beer and other beverages, although the eventual effect will depend on regional weather patterns and operating costs. Ambev se prepara para clima mais quente com El Niño
• Neutral Sentiment: Barclays reaffirmed its Hold rating, indicating the analyst does not see a sufficiently compelling near-term catalyst to change its stance. Barclays Reaffirms Their Hold Rating on Ambev SA
• Neutral Sentiment: Ambev filed its July Form 6-K, reaffirming its U.S. reporting status. The filing is a routine compliance update with limited direct effect on valuation. Ambev July 2026 Form 6-K
• Negative Sentiment: Ambev’s latest results were mixed: adjusted EPS of $0.04 met consensus, but revenue of $3.89 billion fell short of the $4.05 billion estimate. The top-line miss is the clearest reason for investor pressure, suggesting weaker-than-expected sales momentum despite earnings execution. Ambev Q2 2026 Earnings Call Transcript

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.